Data Package for study.
收藏DataCite Commons2025-07-07 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/dataPackages/PR00002909.0
下载链接
链接失效反馈官方服务：
资源简介：
The primary objectives are to identify the highest safe and well-tolerated dose and frequency of BIIB017 (PEGylated Interferon Beta-1a) subcutaneous (SC), within the range of 63 to 188 mcg, when given every other week or every 4 weeks to healthy volunteers (HV).
提供机构：
Vivli
创建时间：
2025-07-07
